Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
September 12, 2024 07:00 ET
|
Genespire
PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
September 12, 2024 01:00 ET
|
Genespire
PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...
Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting
May 09, 2024 12:00 ET
|
Genespire
PRESS RELEASE Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting Data provides preclinical validation for Genespire’s liver-directed lentiviral gene therapy in...
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer
July 07, 2022 02:00 ET
|
Genespire
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer Accomplished executive with extensive preclinical and clinical gene therapy experience joins Genespire to accelerate pipeline to the...
Genespire appoints Philippe Mauberna as Chief Financial Officer
July 13, 2021 07:00 ET
|
Genespire
Genespire appoints Philippe Mauberna as Chief Financial Officer Former Nanobiotix Chief Financial Officer brings extensive experience in international life sciences finance, successful fundraisings...
Genespire Strengthens Management Team with Two Key Appointments
May 05, 2021 07:00 ET
|
Genespire
Genespire Strengthens Management Team with Two Key Appointments Dr. Julianne Smith appointed Chief Development Officer Dr. Smaragda Angelidou appointed as Head of CMC Italy, Milan, 5 May 2021:...
Genespire appoints Jörn Aldag as Chairman of the Board of Directors
July 30, 2020 07:00 ET
|
Genespire
Genespire appoints Jörn Aldag as Chairman of the Board of DirectorsSerial entrepreneur brings exceptional experience from a range of leadership roles Italy, Milan, 30 July 2020: Genespire, a gene...
Genespire and the San Raffaele Telethon Institute for Gene Therapy announce publication in Nature Biotechnology on enhanced gene editing technique in hematopoietic stem cells
June 30, 2020 07:00 ET
|
Genespire
Genespire and the San Raffaele Telethon Institute for Gene Therapy announce publication in Nature Biotechnology on enhanced gene editing technique in hematopoietic stem cells Italy, Milan, 30 June...
Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus
May 13, 2020 07:00 ET
|
Genespire
Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus Pre-clinical data from...
Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus
May 13, 2020 02:00 ET
|
Genespire
Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus Pre-clinical data from...